CD4 and metastatic neoplasm: Indeed, elevated signature scores of Treg and Th1 were linked to worse outcomes in both patients with primary and metastatic liver tumors (Fig. 3J and Additional file 1: Fig. S3C–H), suggesting the impairment of CD4+ T cells and their promoting effects on immune escape of primary and metastatic tumor cells in the liver.